Showing results (1-10 of 258) with videos related to
Sort By:
Pageof 26
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
Metabolomics in multiple sclerosis disease course and progressionPavan Bhargava, Daniel C AnthonyNeurologic Clinics|November 18, 2023
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for TreatmentLarissa Jank, Pavan BhargavaMultiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2016
Metabolomics in multiple sclerosisPavan Bhargava, Peter A CalabresiCurrent Neurology and Neuroscience Reports|September 11, 2014
Gut microbiome and multiple sclerosisPavan Bhargava, Ellen M MowryTherapeutic Advances in Neurological Disorders|November 2, 2016
An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosisPavan Bhargava, Scott D NewsomeCNS Drugs|January 23, 2023
The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple SclerosisDimitrios C Ladakis, Pavan BhargavaJournal of Neuroimmunology|February 12, 2015
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controlsPavan Bhargava, Anne Gocke, Peter A CalabresiBrain : a Journal of Neurology|July 1, 2022
Contribution of B cells to cortical damage in multiple sclerosisPavan Bhargava, Hans-Peter Hartung, Peter A CalabresiEuropean Journal of Immunology|November 7, 2017
Dimethyl fumarate treatment alters NK cell function in multiple sclerosisMatthew D Smith, Peter A Calabresi, Pavan BhargavaPageof 26